Grace L. Allen1
Ashley K. Grahn1
Katerina Kourentzi2
Richard C. Willson2Sean Waldrop3
Jiantao Guo3
Brian K. Kay1*- 1Tango Biosciences, Inc., Chicago, IL, United States
- 2Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX, United States
- 3Department of Chemistry, University of Nebraska at Lincoln, Lincoln, NE, United States
Bacteriophage M13 virions are very stable nanoparticles that can be modified by chemical and genetic methods. The capsid proteins can be functionalized in a variety of chemical reactions without loss of particle integrity. In addition, Genetic Code Expansion (GCE) permits the introduction of non-canonical amino acids (ncAAs) into displayed peptides and proteins. The incorporation of ncAAs into phage libraries has led to the discovery of high-affinity binders with low nanomolar dissociation constant (KD) values that can potentially serve as inhibitors. This article reviews how bioconjugation and the incorporation of ncAAs during translation have expanded the chemistry of peptides and proteins displayed by M13 virions for a variety of purposes.
Introduction
Since the seminal work of Professor George Smith (Smith, 1985) in displaying a protein fragment on the surface of M13 bacteriophage, a large number of peptides and proteins have been displayed for antibody discovery, protein engineering, and mapping protein-protein interactions. While phage-display is a prize-worthy technique (Smith, 2019), it has generally been limited in chemistry to the canonical set of 20 amino acids of L-chirality. Both chemical modification and genetic methods have been used to expand the types of functional groups displayed on the surface of virions.
Chemically modified virions have been used in a variety of applications (Mohan and Weiss, 2016), such as lateral flow assays (Hagström et al., 2015; Kim et al., 2015, 2017), biosensors (Moon et al., 2019), nanomaterials (Petrenko, 2018), nanomedicine (Ulfo et al., 2022), and batteries (Lee et al., 2009). In M13 bacteriophage (Figure 1), there are ∼2,700 copies of the major capsid protein, pVIII, which makes it a desirable target for bulk chemical modification of virions (Kehoe and Kay, 2005). The major capsid protein is 50 amino acids long and it contains a number of residues with functional groups suitable for bioconjugation, such as amines, carboxylic acids, and phenols (Carmody et al., 2021). The reactivity of these functional groups is dependent on steric accessibility, ionization state, and solvent conditions. For example, the ε-amino group of the lysine at position 8 can be derivatized with glutaraldehyde or N-hydroxysuccinimide esters (NHS-esters) to attach fluorescent dyes, biotin, drugs, DNA, enzymes, or gold nanoparticles (Carmody et al., 2021), although the N-terminus of pVIII is preferentially targeted because of its higher solvent accessibility and lower pKa value (Li et al., 2010). While pVIII lacks cysteines, thiolation of primary amines with 2-Iminothiolane (Traut’s Reagent) generates sulfhydryl groups that can be coupled to maleimide-activated antibodies or enzymes. Moreover, ε-amino groups are reactive toward aldehydes that are easily generated by mild periodate-mediated oxidation of the sugars on antibodies or horseradish peroxidase (HRP), enabling favorable conjugation directed away from binding sites and active sites of antibodies or HRP, respectively (Adhikari et al., 2013, 2015). In another scheme, using 4-formyl succinimidyl benzoate, amine groups are converted to aromatic aldehydes that readily react with hydrazide derivatized DNA under mild conditions (Domaille et al., 2013). Carboxylate groups at the C-terminus and within aspartic (D) and glutamic (E) acids of virion coat proteins can be activated with a carbodiimide crosslinker [e.g., EDC (1-ethyl-3-(3-(dimethylamino) propyl)-carbodiimide hydrochloride)]. It is also possible to incorporate a methionine analog, L-azidohomoalanine (Urquhart et al., 2016), in strains of Escherichia coli that are auxotrophic for methionine and produce virions displaying hundreds of azide groups for downstream chemical conjugation.
Figure 1. Cartoon of an M13 bacteriophage virion, three types of chemically reactive groups, and primary structure of the major capsid protein, pVIII. Each virus particle (A) is 900 nanometers long and 7 nanometers wide and contains one single-stranded, circular DNA molecule, and five copies of pIX (yellow), pVII (white), pIII (purple), and pVI (pink), and ∼2,700 copies of pVIII (blue). Chemical groups that are available for conjugation include the α-amino groups on the N-terminus and ε-amino groups of lysines (K) of pVIII, the carboxylate groups at the C-terminus and aspartic (D) and glutamic (E) acids, and the phenol groups of tyrosine (Y) are shown in violet, orange, and fushia, respectively. The primary structure for mature pVIII (B) is shown with the N-terminus, C-terminus, and residues theoretically capable of being chemically modified highlighted in color. It should be noted that the lysines in the anchoring region (KLFKKFTSKAS) of pVIII may not be sterically accessible for chemical modification.
Peptides and proteins that have been displayed on the surface of virions have also been the target of chemical or enzymatic modification. One can engineer a free cysteine (Junutula et al., 2008) for bioconjugation or, alternatively, disulfides in a displayed peptide, which can be reduced and then reacted with a cross-bridging molecule (i.e., linchpin), thereby creating macrocyclic or bicyclic peptides for the purpose of discovering novel peptide ligands of target proteins (Ng and Derda, 2016; Deyle et al., 2017; Chen et al., 2021; Ekanayake et al., 2021). Tyrosine (Y) in pVIII can be selectively activated by laccase to produce a free radical species that can be conjugated to acrylates (Vignali et al., 2018). Virions that have been engineered to display the AviTag (Scholle et al., 2004) or sortase tag (Hess et al., 2012) can be biotinylated by BirA or ligated to a variety of labeled peptides with sortase, respectively. Promising directions in the future will be to exploit the toolbox of enzymes capable of protein ligation (Nuijens et al., 2019; Weeks and Wells, 2020) and the SpyTag/SpyCatcher system (Keeble and Howarth, 2020) to build novel virion structures.
Genetic methods have been separately applied to expanding the chemical space of virions. They are largely based on the pioneering work of Professor Peter Schultz’s research group (Liu et al., 1997; Xiao and Schultz, 2016; Young and Schultz, 2018) on recoding the amber codon (TAG) so that it is recognized by a mutant, suppressor tRNA molecule that is charged with an non-canonical amino acid (ncAA). Figure 2 illustrates the basics of tRNA suppression. One first uses molecular biology techniques to engineer a TAG mutation at a site in the coding region of a protein where the ncAA is desired. When the gene is transcribed, the UAG codon is recognized as a stop codon by the ribosome, thereby terminating translation and yielding a truncated protein; however, if a tRNA has an anti-codon (CUA) that can base pair with the UAG codon in an mRNA, the amino acid attached to the 3’ end of the tRNA will form a peptide bond with the nascent peptide in the ribosome, allowing translation to continue and yield a full-length protein. The introduced ncAA can be any that is compatible with charging by an aminoacyl-tRNA synthetase (aaRS). The amino acid pocket of the pyrrolysyl-tRNA synthetase has been shown to be remarkably malleable to engineering recognition and charging of its cognate tRNA with diverse ncAAs (Wan et al., 2014; Tharp et al., 2018). Stop codon suppression has also been achieved with opal (UGA) (Anderson and Schultz, 2003) and ochre (UAA) (Italia et al., 2019) codons. In addition to suppression of stop codons, an analogous method with quadruplet codons (Magliery et al., 2001; Anderson and Schultz, 2003; Anderson et al., 2004; Neumann et al., 2010; Niu et al., 2013; Wang et al., 2014) has been developed (Figure 2). Mutations in both the aaRS and tRNA, as well as the use of engineered bacterial hosts (Chatterjee et al., 2014), have enhanced suppression efficiency of a variety of quadruplet codons (Guo and Niu, 2022). To date, >200 different ncAAs have been introduced into different proteins by this technique (Xiao and Schultz, 2016), which has been termed Genetic Code Expansion (GCE). Some of GCE’s applications have been to probe the structure and function of proteins, alter their redox potential, introduce fluorophores, infrared, and spin label probes, encode post-translational modifications, and create sites for site-specific bioconjugation. Several recent reviews of how GCE has been used to modify proteins expressed in bacteria, yeast, and mammalian cells can be found elsewhere (Young and Schultz, 2018; Chung et al., 2020; Nikić-Spiegel, 2020; Manandhar et al., 2021; Ros et al., 2021; Shandell et al., 2021; Sanders et al., 2022).
Figure 2. Insertion of ncAAs into peptides or proteins by GCE. (A) An mRNA containing an engineered quadruplet or stop codon for insertion of an ncAA at a designated location in a protein. During translation, the ribosome (purple) decodes the engineered stop codon (B) or quadruplet codon (C) with a tRNA charged with the ncAA (blue). The tRNA anticodon is shown in bold and the growing polypeptide chain is shown in green. (D) Peptide or protein with an ncAA at the desired location.
GCE has been applied to phage-display. Figure 3 shows an E. coli cell containing three circular genomes: a plasmid encoding the orthogonal tRNA and cognate aaRS, a phagemid that carries a truncated form of capsid protein III (pIII), which is fused to the coding region of the displayed peptide or protein containing the suppressible amber codon, and an M13 helper virus. The helper virus encodes 10 proteins necessary for viral replication and assembly; it also contains a mutation that leads to preferential packaging of the phagemid genome over the helper virus genome. Secreted virions will display the recombinant peptide or protein and ncAA, only if suppression is successful. The culture medium is supplemented with the ncAA, where it enters the cell and is used by the engineered aaRS to charge the suppressor tRNA. Table 1 lists some examples of publications describing the incorporation of ncAAs into virions, which are also summarized in more detail below.
Figure 3. Incorporation of ncAAs into phage-displayed constructs. (A) E. coli cell showing three genomes: phagemid with suppressible mutation (TAG, blue) in the coding region (green) of a protein fused to a truncated form of capsid protein pIII (purple), a plasmid encoding an orthogonal aaRS/tRNACUA pair (orange/red), and an M13 helper virus (i.e., K07) encoding full length pIII (black). Each of these genomes carry a different antibiotic resistance marker to allow for selective growth of bacterial cells containing all three. (B) Virions secreted from such cells contain both wild type (black) and recombinant (purple) pIII capsid proteins, the latter of which display the protein of interest (green) incorporating the desired ncAA (blue).
Table 1. Examples of GCE involving M13 virions in the literature.
The earliest experiments of engineered replacement of amino acids with M13 bacteriophage took advantage of its life cycle properties. Scientists at New England Biolabs inserted the opal (TGA) stop codon and a downstream selenocysteine insertion sequence (SECIS) upstream of the signal sequence in pIII (Sandman and Noren, 2000). Viral secretion was dependent on the addition of selenium to the culture medium and the incorporation of selenocysteine was confirmed by chemical reactivity. The efficiency of incorporation was influenced by the choice of nucleotide downstream of the opal codon, although the frequency of TGG revertants, encoding tryptophan, was high. Later, the authors (Beech et al., 2015) utilized the selenocysteine-displaying virions to chemically attach five different adenosine receptor ligands and successfully demonstrated that the pentavalently decorated virions could activate the adenosine A1 receptor, a G protein-coupled receptor (GPCR), of cultured cells. An early example of utilizing stop codon suppression to control the replacement of an amino acid was that of the Schultz group (Pastrnak and Schultz, 2001). They introduced an amber codon in lieu of the asparagine (N) in a 10-mer peptide sequence (PASTTNKDKL) at the N-terminus of pIII of a phage genome. Virions were propagated in an E. coli strain that carried the supE mutation, which encodes a suppressor tRNA that is charged with asparagine. The virions were then used to infect a second bacterial strain that carried a plasmid encoding a yeast tRNA and its cognate aaRS that inserted N into the 10-mer peptide. Only virions secreted by this strain bound well to a monoclonal antibody that had been generated against the 10-mer peptide, demonstrating successful suppression of the stop codon. This proof-of-concept experiment set the stage for engineering aaRSs that could charge their cognate tRNA with ncAAs and suppress amber codons inserted into pIII of virions. Phage-assisted continuous evolution (PACE), phage-assisted non-continuous evolution (PANCE), and phage- and robotic-assisted near-continuous evolution (PRANCE) have enabled rapid laboratory evolution of orthogonal aaRSs over hundreds of generations of mutation, selection, and replication (Esvelt et al., 2011; Bryson et al., 2017; Miller et al., 2020; DeBenedictis et al., 2021, 2022; Fischer et al., 2022). As coat protein pIII is essential for phage, this selection scheme directly links the production and titer of virions with the efficiency of stop codon suppression and incorporation of the desired ncAA in a stop codon inserted into gene III.
The Schultz group was among the first to incorporate ncAAs into displayed peptides and proteins. A variety of ncAAs have been incorporated into peptides permitting bioconjugation (Tian et al., 2004), binding to metal ions (Day et al., 2013), and replacing Zn(II) with Fe(II) for DNA binding domains (Kang et al., 2014). Non-canonical amino acids have also been incorporated into human single-chain variable fragments (scFvs) displayed on virions. In fact, a sulfotyrosine has been incorporated into an scFv that contributed to binding to HIV glycoprotein 120 (Liu et al., 2008). The electrophilic amino acid p-boronophenylalanine has also been successfully incorporated into an scFv, where it can cross-link to a sugar (Liu et al., 2009).
Insertion of ncAAs into phage-displayed peptides offers a number of experimental opportunities. First, it can increase the chemical diversity of the combinatorial peptide libraries for the purpose of identifying novel peptide ligands to a target protein. Second, the ncAA can serve as a site for bioconjugation of ligands that already bind to a target, such as an enzyme, for the purpose of discovering a peptide inhibitor (Figure 4A). For example, in a recent report (Tharp et al., 2020), Nε -butyryl-L-lysine (BuK), thiobutyryl (tBuK), and thiomyristoyl (tMyK) analogs were introduced in a combinatorial 11-mer library for the discovery of inhibitors of the NAD-dependent deacetylase, Sirtuin 2 (Sirt2). The ability to genetically encode post-translational modifications by GCE should prove useful for identifying inhibitors of various enzymes and cellular binding proteins in the future.
Figure 4. Current applications of GCE in phage display. (A) Conjugation of a ligand to an ncAA allows direct binding to the active site of a target enzyme. A ligand (orange) may be conjugated to an ncAA (blue) positioned within a peptide (green) and displayed on pIII of an M13 virion. After multiple rounds of phage-display affinity selections to the target protein, a consensus amino acid sequence flanking the ligand conjugated ncAA will be revealed. The final product is an optimized sequence with strong affinity for the target protein. (B) Macrocycle formation via spontaneous cyclization. The cysteine-reactive ncAA O2bey (O-(2-bromoethyl)-tyrosine, blue) spontaneously cyclizes with a cysteine residue (purple) to form a macrocycle that is displayed on pIII of an M13 virion. (C) Dual fluorophore labeling of a phage-displayed protein. Orthogonal incorporation of the ncAAs PrpF (p-propargyloxy-phenylalanine) and CypK (cyclopropene derivative of lysine) into the variable light chain (VL, yellow) and variable heavy chain (VH, orange) regions of a single-chain variable fragment (scFv) of a recombinant antibody. This allows for dual labeling with azide- and tetrazine-fluorophores, respectively, as depicted by the black and white stars.
Recently, GCE has also been used to incorporate ncAAs for the purpose of cyclizing phage-displayed peptides. This effort represents an alternative route for cyclizing phage-displayed peptides to generate macrocycles with novel structures and the potential to inhibit protein-protein interactions in therapeutic applications (Deyle et al., 2017). In the original approach (Heinis et al., 2009), a library of peptides with three fixed cysteines was reduced and then reacted with a trifunctional compound, termed a “linchpin,” thereby creating bicyclic peptides. GCE has been used for the same purpose: researchers have built libraries of virions displaying CX6Z (Wang et al., 2019; Tharp et al., 2020) and ZX6C (Owens et al., 2020), where X represents an amino acid encoded by NNK codons and Z is an ncAA encoded by the TAG codon that is capable of reacting with the adjacent cysteine residue to form a macrocycle (Figure 4B). These libraries were screened by affinity selection and yielded nanomolar inhibitors of Tobacco Etch Virus (TEV) protease (Wang et al., 2019), Sirt2 (Tharp et al., 2020), and Kelch-like ECH-associated protein 1 (Keap1) and Sonic Hedgehog (Shh) (Owens et al., 2020). The cyclized peptides all showed stronger affinity to their targets than their linear counterparts. It will be exciting to see how this approach unfolds over time. Perhaps covalent inhibitors can be discovered by incorporating ncAAs capable of cross-linking with a target as reported elsewhere (Chen et al., 2021).
GCE has been used to site-specifically dual-fluorophore-label proteins displayed on the surface of M13 virions (Figure 4C). Suppression of amber and quadruplet codons facilitated the insertion of Nε–[((2-methylcycloprop-2-en1-yl)methoxy)carbonyl]-l-lysine (CypK) and p-propargyloxy-l-phenyl-alanine (PrpF) into separate sites of a phage-displayed anti-Her2 scFv (Oller-Salvia and Chin, 2019). The orthogonal Methanococus janaaschii (Mj) tyrosyl-trRNA synthetase (MjTyrRs)/tRNACUA pair was used to incorporate PrpF, which was labeled with an azide-fluorophore. The pyrrolysyl-tRNA synthetase (PylRS)/tRNA orthogonal pair was used to incorporate CypK, which was labeled with a tetrazine-fluorophore. By exploring a variety of variables, the authors were able to achieve near wild-type display levels of the scFv for dual labeled, phage-displayed proteins. This system allows for mutually orthogonal and site-specific, dual-labeling of a protein in a one-pot reaction.
Two other recent publications of note describe the incorporation of an ncAA into the target of an affinity selection experiment (Figure 5A). Human interleukin-1β (IL-1β) and complement 5a (C5a) proteins were prepared in bacterial cells with p-benzoyl-L-phenylalanine utilizing GCE and used to affinity select a phage-display scFv library (Chen et al., 2020). By cross-linking virions to the targets with ultraviolet (UV) irradiation and washing away non-covalently bound virions with pH 2.0 glycine, the bound virions were selectively recovered by trypsin digestion. Over one-third of the recovered scFvs could bind to the targets without cross-linking and their affinities could be improved by mutagenesis. Thus, GCE can be used to steer production of antibodies to epitopes of interest. In a related approach, the 3-nitrotyrosine (nitroTyr) modified form (nY133) of the 14-3-3 signaling protein was used to immunize alpacas and two nanobodies that recognize this post-translational modification at position 133 were recovered by phage-display (Van Fossen et al., 2022).
Figure 5. Future applications of GCE in phage display. (A) Epitope steering. If the target protein (cyan) has incorporated a photoactivatable, crosslinking ncAA (pBpa, blue), recovery of virions can be biased toward those that bind to the labeled epitope. (B) Profiling the specificity of domains that recognize peptides that carry post-translational modifications. Phosphoamino acids such as phosphoserine (pS), phosphothreonine (pT), and phosphotyrosine (pY) can be incorporated into phage-displayed combinatorial peptide libraries or recombinant proteins. Affinity selections can be performed with these constructs to elucidate the specificity of protein interaction domains (top) as well as generate affinity reagents that recognize phosphoepitopes (bottom).
Perspectives
Several challenges and opportunities remain for optimizing GCE for phage-display. First, in order to incorporate a particular ncAA, the ncAA or its precursor must be supplied to the culture medium for it to cross the bacterial cell membrane where it can cross the cell membrane and be used by an aaRS to charge the suppressor tRNA. This challenge may be solved through the use of mutated strains, the expression of exogenous transporters, and the design of gene clusters capable of cellular synthesis of certain ncAAs. Second the use of bacterial strains that lack release factor 1 (RF-1) (Lajoie et al., 2013; Mukai et al., 2015; Fredens et al., 2019) will suppress TAG codons more efficiently.
One might ask, what are some possible experiments that can be accomplished by combining GCE and phage-display? An example that comes to mind is the production of phage-displayed combinatorial peptide libraries that carry phosphoserine (Park et al., 2011; Zhu et al., 2021), phosphothreonine (Zhang et al., 2017), or phosphotyrosine (Hoppmann et al., 2017; Luo et al., 2017). Such libraries could then be used to define the specificity of naturally occurring protein interaction modules that recognize phosphoepitopes (Yaffe and Elia, 2001; Liang and Van Doren, 2008; Marasco and Carlomagno, 2020), such as Src Homology 2 (SH2), phosphotyrosine binding domains (PTB), 14-3-3 proteins, BRCA1 C-terminus (BRCT) domains, and Forkhead-associated (FHA) domains (Figure 5B). The same libraries could be used to define the specificity of antibodies generated to phosphopeptides (Mandell, 2003). It might even be possible to construct libraries that display more than one post-translational modification (Qin and Liu, 2022) to elucidate the specificity of those domains that recognize two post-translational modifications simultaneously. This general approach should be applicable to defining the specificity of cellular proteins that bind other post-translational modifications. Another application might be to generate recombinant proteins that bear a phosphorylated amino acid at a position found in cellular proteins and then generate recombinant affinity reagents that recognize the folded, phosphorylated target (Figure 5B). Thus, it may even be possible to use this general approach to generate recombinant antibodies to many of the site-specific post-translational modifications of interest to cell biologists and biochemists. Finally, it is likely that chemically-and genetically-modified virions will prove beneficial in such emerging applications of phage in drug delivery (Karimi et al., 2016), immune-oncology (Foglizzo and Marchiò, 2021), synthetic biology (Lemire et al., 2018), tissue regeneration (Cao et al., 2019), and vaccines (Henry et al., 2015; González-Mora et al., 2020).
Author contributions
AG and GA prepared the figures. All the authors contributed to the writing or editing the manuscript.
Funding
Funding was provided by grant 1 R43 GM146514-01 from the National Institutes of Health.
Conflict of Interest
GA, AG, and BK were employed of a biotech start-up company (Tango Biosciences, Inc.).
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Adhikari, M., Dhamane, S., Hagström, A. E., Garvey, G., Chen, W. H., Kourentzi, K., et al. (2013). Functionalized viral nanoparticles as ultrasensitive reporters in lateral-flow assays. Analyst 138, 5584–5587. doi: 10.1039/c3an00891f
Adhikari, M., Strych, U., Kim, J., Goux, H., Dhamane, S., Poongavanam, M. V., et al. (2015). Aptamer-phage reporters for ultrasensitive lateral flow assays. Analy. Chem. 87, 11660–11665. doi: 10.1021/acs.analchem.5b00702
Anderson, J. C., and Schultz, P. G. (2003). Adaptation of an orthogonal archaeal leucyl-tRNA and synthetase pair for four-base, amber, and opal suppression. Biochemistry 42, 9598–9608. doi: 10.1021/bi034550w
Anderson, J. C., Wu, N., Santoro, S. W., Lakshman, V., King, D. S., and Schultz, P. G. (2004). An expanded genetic code with a functional quadruplet codon. Proc. Natl. Acad. Sci. U S A 101, 7566–7571.
Beech, J., Saleh, L., Frentzel, J., Figler, H., Corrêa, I. R., Baker, B., et al. (2015). Multivalent site-specific phage modification enhances the binding affinity of receptor ligands. Bioconjug. Chem. 26, 529–536. doi: 10.1021/acs.bioconjchem.5b00011
Bryson, D. I., Fan, C., Guo, L. T., Miller, C., Söll, D., and Liu, D. R. (2017). Continuous directed evolution of aminoacyl-tRNA synthetases. Nat. Chem. Biol. 13, 1253–1260.
Cao, B., Li, Y., Yang, T., Bao, Q., Yang, M., and Mao, C. (2019). Bacteriophage-based biomaterials for tissue regeneration. Adv. Drug Del. Rev. 145, 73–95. doi: 10.1016/j.addr.2018.11.004
Carmody, C. M., Goddard, J. M., and Nugen, S. R. (2021). Bacteriophage Capsid Modification by Genetic and Chemical Methods. Bioconjug. Chem. 32, 466–481.
Chatterjee, A., Lajoie, M. J., Xiao, H., Church, G. M., and Schultz, P. G. (2014). A bacterial strain with a unique quadruplet codon specifying non-native amino acids. Chembiochem 15, 1782–1786. doi: 10.1002/cbic.201402104
Chen, L., Zhu, C., Guo, H., Li, R., Zhang, L., Xing, Z., et al. (2020). Epitope-directed antibody selection by site-specific photocrosslinking. Sci. Adv. 6:eaaz7825. doi: 10.1126/sciadv.aaz7825
Chen, S., Lovell, S., Lee, S., Fellner, M., Mace, P. D., and Bogyo, M. (2021). Identification of highly selective covalent inhibitors by phage display. Nat. Biotechnol. 39, 490–498. doi: 10.1038/s41587-020-0733-7
Chung, C. Z., Amikura, K., and Söll, D. (2020). Using genetic code expansion for protein biochemical studies. Front. Bioeng. Biotechnol. 8:598577.
Day, J. W., Kim, C. H., Smider, V. V., and Schultz, P. G. (2013). Identification of metal ion binding peptides containing unnatural amino acids by phage display. Bioorg. Med. Chem. Lett. 23, 2598–2600. doi: 10.1016/j.bmcl.2013.02.106
DeBenedictis, E. A., Carver, G. D., Chung, C. Z., Söll, D., and Badran, A. H. (2021). Multiplex suppression of four quadruplet codons via tRNA directed evolution. Nat. Commun. 12:5706. doi: 10.1038/s41467-021-25948-y
DeBenedictis, E. A., Chory, E. J., Gretton, D. W., Wang, B., Golas, S., and Esvelt, K. M. (2022). Systematic molecular evolution enables robust biomolecule discovery. Nat. Methods 19, 55–64. doi: 10.1038/s41592-021-01348-4
Deyle, K., Kong, X. D., and Heinis, C. (2017). Phage selection of cyclic peptides for application in research and drug development. Acc. Chem. Res. 50, 1866–1874.
Domaille, D. W., Lee, J. H., and Cha, J. N. (2013). High density DNA loading on the M13 bacteriophage provides access to colorimetric and fluorescent protein microarray biosensors. Chem. Commun. 49, 1759–1761. doi: 10.1039/c3cc38871a
Ekanayake, A. I., Sobze, L., Kelich, P., Youk, J., Bennett, N. J., Mukherjee, R., et al. (2021). Genetically encoded fragment-based discovery from phage-displayed macrocyclic libraries with genetically encoded unnatural pharmacophores. J. Am. Chem. Soc. 143, 5497–5507. doi: 10.1021/jacs.1c01186
Esvelt, K. M., Carlson, J. C., and Liu, D. R. (2011). A system for the continuous directed evolution of biomolecules. Nature 472, 499–503.
Fischer, J. T., Söll, D., and Tharp, J. M. (2022). Directed evolution of methanomethylophilus alvus Pyrrolysyl-tRNA synthetase generates a hyperactive and highly selective variant. Front. Mol. Biosci. 9:850613. doi: 10.3389/fmolb.2022.850613
Foglizzo, V., and Marchiò, S. (2021). Bacteriophages as Therapeutic and Diagnostic Vehicles in Cancer. Pharmaceuticals 14:161.
Fredens, J., Wang, K., de la Torre, D., Funke, L. F. H., Robertson, W. E., Christova, Y., et al. (2019). Total synthesis of Escherichia coli with a recoded genome. Nature 569, 514–518.
González-Mora, A., Hernández-Pérez, J., Iqbal, H. M. N., Rito-Palomares, M., and Benavides, J. (2020). Bacteriophage-based vaccines: a potent approach for antigen delivery. Vaccines 8:504. doi: 10.3390/vaccines8030504
Guo, J., and Niu, W. (2022). Genetic code expansion through quadruplet codon decoding. J. Mol. Biol. 434:167346.
Hagström, A. E., Garvey, G., Paterson, A. S., Dhamane, S., Adhikari, M., Estes, M. K., et al. (2015). Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay. PLoS One 10:e0126571. doi: 10.1371/journal.pone.0126571
Heinis, C., Rutherford, T., Freund, S., and Winter, G. (2009). Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat. Chem. Biol. 5, 502–507.
Henry, K. A., Arbabi-Ghahroudi, M., and Scott, J. K. (2015). Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold. Front. Microbiol. 6:755. doi: 10.3389/fmicb.2015.00755
Hess, G. T., Cragnolini, J. J., Popp, M. W., Allen, M. A., Dougan, S. K., Spooner, E., et al. (2012). M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins. Bioconjug. Chem. 23, 1478–1487. doi: 10.1021/bc300130z
Hoppmann, C., Wong, A., Yang, B., Li, S., Hunter, T., Shokat, K. M., et al. (2017). Site-specific incorporation of phosphotyrosine using an expanded genetic code. Nat. Chem. Biol. 13, 842–844.
Italia, J. S., Addy, P. S., Erickson, S. B., Peeler, J. C., Weerapana, E., and Chatterjee, A. (2019). Mutually orthogonal nonsense-suppression systems and conjugation chemistries for precise protein labeling at up to three distinct sites. J. Am. Chem. Soc. 141, 6204–6212. doi: 10.1021/jacs.8b12954
Junutula, J. R., Bhakta, S., Raab, H., Ervin, K. E., Eigenbrot, C., Vandlen, R., et al. (2008). Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs. J. Immunolog. Methods 332, 41–52. doi: 10.1016/j.jim.2007.12.011
Kang, M., Light, K., Ai, H. W., Shen, W., Kim, C. H., Chen, P. R., et al. (2014). Evolution of iron(II)-finger peptides by using a bipyridyl amino acid. Chembiochem 15, 822–825. doi: 10.1002/cbic.201300727
Karimi, M., Mirshekari, H., Moosavi Basri, S. M., Bahrami, S., Moghoofei, M., and Hamblin, M. R. (2016). Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos. Adv. Drug Del. Rev. 106, 45–62. doi: 10.1016/j.addr.2016.03.003
Keeble, A. H., and Howarth, M. (2020). Power to the protein: enhancing and combining activities using the Spy toolbox. Chem. Sci. 11, 7281–7291. doi: 10.1039/d0sc01878c
Kehoe, J. W., and Kay, B. K. (2005). Filamentous phage display in the new millennium. Chem. Rev. 105, 4056–4072. doi: 10.1021/cr000261r
Kim, J., Adhikari, M., Dhamane, S., Hagström, A. E., Kourentzi, K., Strych, U., et al. (2015). Detection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay. ACS Appl. Mater. Interfaces 7, 2891–2898. doi: 10.1021/am5082556
Kim, J., Vu, B., Kourentzi, K., Willson, R. C., and Conrad, J. C. (2017). Increasing binding efficiency via reporter shape and flux in a viral nanoparticle lateral-flow assay. ACS Appl. Mater. Interfaces 9, 6878–6884. doi: 10.1021/acsami.6b15728
Lajoie, M. J., Rovner, A. J., Goodman, D. B., Aerni, H. R., Haimovich, A. D., Kuznetsov, G., et al. (2013). Genomically recoded organisms expand biological functions. Science 342, 357–360.
Lee, Y. J., Yi, H., Kim, W. J., Kang, K., Yun, D. S., Strano, M. S., et al. (2009). Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes. Science 324, 1051–1055. doi: 10.1126/science.1171541
Lemire, S., Yehl, K. M., and Lu, T. K. (2018). Phage-based applications in synthetic biology. Annu. Rev. Virol. 5, 453–476.
Li, K., Chen, Y., Li, S., Nguyen, H. G., Niu, Z., You, S., et al. (2010). Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjug. Chem. 21, 1369–1377. doi: 10.1021/bc900405q
Liang, X., and Van Doren, S. R. (2008). Mechanistic insights into phosphoprotein-binding FHA domains. Acc. Chem. Res. 41, 991–999. doi: 10.1021/ar700148u
Liu, C. C., Mack, A. V., Brustad, E. M., Mills, J. H., Groff, D., Smider, V. V., et al. (2009). Evolution of proteins with genetically encoded “chemical warheads”. J. Am. Chem. Soc. 131, 9616–9617. doi: 10.1021/ja902985e
Liu, C. C., Mack, A. V., Tsao, M. L., Mills, J. H., Lee, H. S., Choe, H., et al. (2008). Protein evolution with an expanded genetic code. Proc. Natl. Acad. Sci. U S A 105, 17688–17693.
Liu, D. R., Magliery, T. J., Pastrnak, M., and Schultz, P. G. (1997). Engineering a tRNA and aminoacyl-tRNA synthetase for the site-specific incorporation of unnatural amino acids into proteins in vivo. Proc. Natl. Acad. Sci. U S A 94, 10092–10097.
Luo, X., Fu, G., Wang, R. E., Zhu, X., Zambaldo, C., Liu, R., et al. (2017). Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria. Nat. Chem. Biol. 13, 845–849. doi: 10.1038/nchembio.2405
Magliery, T. J., Anderson, J. C., and Schultz, P. G. (2001). Expanding the genetic code: selection of efficient suppressors of four-base codons and identification of “shifty” four-base codons with a library approach in Escherichia coli. J. Mol. Biol. 307, 755–769. doi: 10.1006/jmbi.2001.4518
Manandhar, M., Chun, E., and Romesberg, F. E. (2021). Genetic code expansion: inception, development, commercialization. J. Am. Chem. Soc. 143, 4859–4878. doi: 10.1021/jacs.0c11938
Mandell, J. W. (2003). Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology. Am. J. Pathol. 163, 1687–1698.
Marasco, M., and Carlomagno, T. (2020). Specificity and regulation of phosphotyrosine signaling through SH2 domains. J. Struct. Biol. X 4:100026.
Miller, S. M., Wang, T., and Liu, D. R. (2020). Phage-assisted continuous and non-continuous evolution. Nat. Protoc. 15, 4101–4127.
Mohan, K., and Weiss, G. A. (2016). Chemically modifying viruses for diverse applications. ACS Chem. Biol. 11, 1167–1179.
Moon, J. S., Choi, E. J., Jeong, N. N., Sohn, J. R., Han, D. W., and Oh, J. W. (2019). Research Progress of M13 Bacteriophage-Based Biosensors. Nanomaterials 9:E1448. doi: 10.3390/nano9101448
Mukai, T., Hoshi, H., Ohtake, K., Takahashi, M., Yamaguchi, A., Hayashi, A., et al. (2015). Highly reproductive Escherichia coli cells with no specific assignment to the UAG codon. Sci. Rep. 5:9699. doi: 10.1038/srep09699
Neumann, H., Wang, K., Davis, L., Garcia-Alai, M., and Chin, J. W. (2010). Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 464, 441–444. doi: 10.1038/nature08817
Ng, S., and Derda, R. (2016). Phage-displayed macrocyclic glycopeptide libraries. Org. Biomol. Chem. 14, 5539–5545. doi: 10.1039/c5ob02646f
Nikić-Spiegel, I. (2020). Expanding the genetic code for neuronal studies. Chembiochem 21, 3169–3179.
Niu, W., Schultz, P. G., and Guo, J. (2013). An expanded genetic code in mammalian cells with a functional quadruplet codon. ACS Chem. Biol. 8, 1640–1645.
Nuijens, T., Toplak, A., Schmidt, M., Ricci, A., and Cabri, W. (2019). Natural occurring and engineered enzymes for peptide ligation and cyclization. Front. Chem. 7:829.
Oller-Salvia, B., and Chin, J. W. (2019). Efficient phage display with multiple distinct non-canonical amino acids using orthogonal ribosome-mediated genetic code expansion. Angew. Chem. Int. Ed. Engl. 58, 10844–10848. doi: 10.1002/anie.201902658
Owens, A. E., Iannuzzelli, J. A., Gu, Y., and Fasan, R. (2020). MOrPH-PhD: an integrated phage display platform for the discovery of functional genetically encoded peptide macrocycles. ACS Cent. Sci. 6, 368–381.
Park, H. S., Hohn, M. J., Umehara, T., Guo, L. T., Osborne, E. M., Benner, J., et al. (2011). Expanding the genetic code of Escherichia coli with phosphoserine. Science 333, 1151–1154.
Pastrnak, M., and Schultz, P. G. (2001). Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo. Bioorg. Med. Chem. 9, 2373–2379. doi: 10.1016/s0968-0896(01)00157-2
Petrenko, V. A. (2018). Landscape phage: evolution from phage display to nanobiotechnology. Viruses 10:E311.
Qin, X., and Liu, T. (2022). Recent advances in genetic code expansion techniques for protein phosphorylation studies. J. Mol. Biol. 434:167406.
Ros, E., Torres, A. G., Ribas, and de Pouplana, L. (2021). Learning from nature to expand the genetic code. Trends Biotechnol. 39, 460–473.
Sanders, J., Hoffmann, S. A., Green, A. P., and Cai, Y. (2022). New opportunities for genetic code expansion in synthetic yeast. Curr. Opin. Biotechnol. 75:102691. doi: 10.1016/j.copbio.2022.102691
Sandman, K. E., and Noren, C. J. (2000). The efficiency of Escherichia coli selenocysteine insertion is influenced by the immediate downstream nucleotide. Nucleic Acids Res. 28, 755–761. doi: 10.1093/nar/28.3.755
Scholle, M. D., Collart, F. R., and Kay, B. K. (2004). In vivo biotinylated proteins as targets for phage-display selection experiments. Protein Expr. Purif. 37, 243–252.
Shandell, M. A., Tan, Z., and Cornish, V. W. (2021). Genetic code expansion: a brief history and perspective. Biochemistry 60, 3455–3469. doi: 10.1021/acs.biochem.1c00286
Smith, G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315–1317. doi: 10.1126/science.4001944
Smith, G. P. (2019). Phage display: simple evolution in a petri dish (nobel?lecture). Angew. Chem. Int. Ed. Engl. 58, 14428–14437. doi: 10.1002/anie.201908308
Tharp, J. M., Ehnbom, A., and Liu, W. R. (2018). tRNAPyl: Structure, function, and applications. RNA Biol. 15, 441–452. doi: 10.1080/15476286.2017.1356561
Tharp, J. M., Hampton, J. T., Reed, C. A., Ehnbom, A., Chen, P. C., Morse, J. S., et al. (2020). An amber obligate active site-directed ligand evolution technique for phage display. Nat. Commun. 11:1392. doi: 10.1038/s41467-020-15057-7
Tian, F., Tsao, M. L., and Schultz, P. G. (2004). A phage display system with unnatural amino acids. J. Am. Chem. Soc. 126, 15962–15963.
Ulfo, L., Cantelli, A., Petrosino, A., Costantini, P. E., Nigro, M., Starinieri, F., et al. (2022). Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy. Nanoscale 14, 632–641. doi: 10.1039/d1nr06053h
Urquhart, T., Daub, E., and Honek, J. F. (2016). Bioorthogonal modification of the major sheath protein of bacteriophage M13: extending the versatility of bionanomaterial scaffolds. Bioconjug. Chem. 27, 2276–2280. doi: 10.1021/acs.bioconjchem.6b00460
Van Fossen, E. M., Grutzius, S., Ruby, C. E., Mourich, D. V., Cebra, C., Bracha, S., et al. (2022). Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins. Front. Chem. 10:835229. doi: 10.3389/fchem.2022.835229
Vignali, V., Miranda, S., Lodoso-Torrecilla, I., van Nisselroy, C. A. J., Hoogenberg, B. J., Dantuma, S., et al. (2018). Biocatalytically induced surface modification of the tobacco mosaic virus and the bacteriophage M13. Chem. Commun. 55, 51–54. doi: 10.1039/c8cc08042a
Wan, W., Tharp, J. M., and Liu, W. R. (2014). Pyrrolysyl-tRNA synthetase: an ordinary enzyme but an outstanding genetic code expansion tool. Biochim. Biophys. Acta 1844, 1059–1070. doi: 10.1016/j.bbapap.2014.03.002
Wang, K., Sachdeva, A., Cox, D. J., Wilf, N. M., Lang, K., Wallace, S., et al. (2014). Optimized orthogonal translation of unnatural amino acids enables spontaneous protein double-labelling and FRET. Nat. Chem. 6, 393–403. doi: 10.1038/nchem.1919
Wang, X. S., Chen, P. C., Hampton, J. T., Tharp, J. M., Reed, C. A., Das, S. K., et al. (2019). A genetically encoded, phage-displayed cyclic-peptide library. Angew. Chem. Int. Ed. Engl. 58, 15904–15909.
Weeks, A. M., and Wells, J. A. (2020). Subtiligase-catalyzed peptide ligation. Chem. Rev. 120, 3127–3160.
Xiao, H., and Schultz, P. G. (2016). At the interface of chemical and biological synthesis: an expanded genetic code. Cold Spring Harb. Perspect. Biol. 8:a023945.
Yaffe, M. B., and Elia, A. E. (2001). Phosphoserine/threonine-binding domains. Curr. Opin. Cell Biol. 13, 131–138.
Young, D. D., and Schultz, P. G. (2018). Playing with the molecules of Life. ACS Chem. Biol. 13, 854–870.
Zhang, M. S., Brunner, S. F., Huguenin-Dezot, N., Liang, A. D., Schmied, W. H., Rogerson, D. T. et al. (2017). Biosynthesis and genetic encoding of phosphothreonine through parallel selection and deep sequencing. Nat. Methods 14, 729–736. doi: 10.1038/nmeth.4302
Keywords: bioconjugation, phage-display, stop codon suppression, peptide, cyclization, cross-linking, combinatorial peptide libraries, antibody fragments
Citation: Allen GL, Grahn AK, Kourentzi K, Willson RC, Waldrop S, Guo J and Kay BK (2022) Expanding the chemical diversity of M13 bacteriophage. Front. Microbiol. 13:961093. doi: 10.3389/fmicb.2022.961093
Received: 03 June 2022; Accepted: 04 July 2022;
Published: 08 August 2022.
Edited by:
Yoichi Takakusagi, National Institutes for Quantum and Radiological Science and Technology, JapanReviewed by:
Piergiuseppe De Berardinis, Consiglio Nazionale delle Ricerche (Bologna), ItalyNoah Reynolds, University of Illinois at Springfield, United States
Copyright © 2022 Allen, Grahn, Kourentzi, Willson, Waldrop, Guo and Kay. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Brian K. Kay, YmtheUB1aWMuZWR1